Nandrolone Decanoate
Status
No approved product. FDA-approved labeling previously existed as Deca-Durabolin (NDA 013132) and generics for anaemia of renal insufficiency; Drugs@FDA lists every human nandrolone product as discontinued (retrieved 25 October 2026). Anabolic steroids are Schedule III controlled substances and carry class labeling on peliosis hepatis, liver cell tumours and blood lipid changes.
What it is
A long-acting anabolic steroid with clinical history in anemia and cachexia.
What published research measured
A 19-nortestosterone anabolic steroid with a genuine clinical literature — it held approval for anaemia of chronic renal failure and has been studied in HIV-associated wasting and in dialysis patients, with trials reporting increases in lean mass. Two properties distinguish it from testosterone and are well documented. It is a progesterone receptor agonist, which accounts for the pattern of sexual dysfunction reported on it that does not respond to managing oestrogen. And it suppresses the gonadal axis unusually persistently — recovery of endogenous testosterone after nandrolone is slower than after testosterone esters in published follow-up. Its metabolites are detectable in urine for many months, which matters for anyone subject to testing. Prohibited at all times under WADA class S1.1.
Source
Anabolic steroid class labeling on hepatic and lipid effects · WADA Prohibited List, class S1.1
Sources
No linked primary source is on file for this entry yet.
Educational use only, never medical advice. No doses.